<DOC>
	<DOCNO>NCT02584725</DOCNO>
	<brief_summary>The purpose study determine effect increase dos tranexamic acid ( TXA ) limit blood loss total knee total hip arthroplasty define change hemoglobin pre-operative baseline first post-operative day .</brief_summary>
	<brief_title>Tranexamic Acid Dosing Total Joint Arthroplasty</brief_title>
	<detailed_description>The study prospective , randomize , double-blinded trial compare three different dos TXA ( 5mg/kg , 10mg/kg , 15mg/kg ) decrease blood loss total knee total hip arthroplasty . Patients undergoing total knee arthroplasty total hip arthroplasty analyze separately , sub-group analysis . The primary endpoint change hemoglobin baseline first post-operative day ( POD # 1 ) . Patients initially identify orthopedic surgeon meet inclusion exclusion criterion . They inform study provide consent form office , able review prior date surgery . If patient wish participate , formal write consent complete one study investigator member regional anesthesia team . Patients randomize one three group . The anesthesia team responsible subject patient 's care receive two twenty milliliter syringe medication . The syringe label `` Study medication # 1 '' administer intravenously 20 minute begin start surgical skin preparation , syringe label `` Study medication # 2 '' administer 20 minute begin start surgical wound closure . The syrinx group 1 ( low-dose TXA ) contain 5mg/kg TXA , dilute 20 milliliter saline . The syrinx group 2 ( moderate-dose TXA ) contain 10mg/kg TXA , dilute 20 milliliter saline . The syrinx group 3 ( high-dose TXA ) contain 15mg/kg TXA , dilute 20 milliliter saline . The anesthesia team document total intra-operative estimate blood loss well amount blood suction canister end surgery ( calculated volume suction bucket minus volume irrigation use ) . The intraoperative course standardize patient include study . For total knee arthroplasty patient , anesthesia consist long-acting femoral adductor canal peripheral nerve block , follow standardized spinal anesthetic use 15mg plain isobaric bupivacaine . For total hip arthroplasty patient , anesthesia consist standardize spinal anesthetic use 15mg plain isobaric bupivacaine . In patient spinal anesthesia contraindicate refuse , general anesthesia perform patient exclude study . All patient initially enrol , exclude secondary administration general anesthetic analyze via intention-to-treat method . Administration intravenous crystalloid solution per discretion anesthesia team participate intra-operative portion patient 's care , document purpose study anesthesia team . On PODs # 0 , # 1 # 2 , patient undergo standard post-operative blood work include complete blood count . When work physical therapy POD # 1 POD # 2 , assessment ability sit , stand , walk ( yes/no ) record . Assessment pain score via VAS ( 0-10 scale , 0 pain 10 bad 05/26/2016 pain ) record POD # 1 POD # 2 . Assessment subjective sense overall wellbeing ( 0-10 scale , 0 bad patient ever felt , 10 represent pre-operative baseline ) record POD # 1 # 2 . Patients also monitor via clinical exam incidence seizure , transient ischemic attack , stroke , myocardial infarction , deep venous thrombosis , pulmonary embolus first 48 post-operatively .</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients undergo primary unilateral total knee arthroplasty primary unilateral total hip arthroplasty spinal anesthesia Columbia University Medical Center/ New York Presbyterian Hospital . NonEnglish speaking . Patient refusal participate . Weight exceed 100kg . Baseline hemoglobin less 10 . Repeat , revision , bilateral surgery . Known sensitivity allergy Tranexamic Acid . Active intravascular clotting . History coagulopathy congenital thrombophilia . Thromboembolic event 12 month prior enrollment . Percutaneous coronary intervention require drug elute stent 12 month prior enrollment . History anticoagulant medication use unless stop prior surgery recommend accordance American Society Regional Anesthesia Guidelines . Use general anesthetic current anesthetic . Blood transfusion hemoglobin value deviate study 's transfusion protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Total Joint Arthroplasty</keyword>
	<keyword>Intraoperative Blood Loss</keyword>
</DOC>